FONAR Corporation (FONR) Stock

About FONAR Corporation

FONAR Corporation, along with its affiliated entities, is primarily engaged in the research, development, manufacturing, and commercialization of magnetic resonance imaging (MRI) systems within the United States. These sophisticated scanners are instrumental in the detection and diagnosis of various human diseases. The company's operations are divided into two distinct divisions: a Medical Equipment segment and a Physician Management and Diagnostic Services segment. A flagship product is their innovative Upright MRI scanner, which offers the unique capability of imaging patients in weight-bearing postures such as standing, sitting, bending, or traditional supine positions. This allows for the observation of conditions that manifest under natural gravitational stress. Furthermore, under its Physician Management segment, FONAR provides a comprehensive suite of non-medical management and administrative support services. These encompass areas like billing and collections, professional credentialing, contract negotiation, compliance consultation, IT procurement, human resources (including hiring, training, and supervision of non-clinical staff), medical record archival, office space and equipment provision, maintenance, accounting, and assistance with regulatory adherence, as well as the formulation and execution of practice growth and marketing initiatives. FONAR maintains a significant presence in diagnostic imaging services, directly owning and operating five facilities in Florida. Additionally, it oversees the management of 39 MRI scanning centers, with 25 located in New York and 14 throughout Florida. The company strategically markets its advanced MRI technology to both independent diagnostic imaging centers and hospitals. Incorporated in 1978, FONAR Corporation is headquartered in Melville, New York.

FONAR Corporation is led by CEO Timothy R. Damadian, employs 520 people, headquartered in US, publicly traded since 1981.

FONAR Corporation (FONR) stock trades at $19.09 with a market capitalization of $117.76M. The stock is valued at a price-to-earnings (P/E) ratio of 15.33, price-to-book of 0.67, price-to-sales of 1.11. Over the past 52 weeks the stock has ranged between $13.62 and $19.16, and currently trades at or near its 52-week high.

On profitability, FONAR Corporation generates a return on equity (ROE) of 4.62%, return on capital employed of 7.50%, an operating margin of 11.54%, a net profit margin of 6.35%.

Official website: www.fonar.com

FONAR Corporation by the numbers, 2016–2025

Between 2016 and 2025 FONAR Corporation reported revenue of $73.0M rising to $104.0M, a change of +42.5% across 10 years. Compounded, revenue has grown 3.9% a year over five years, 2.0% over three, 1.0% over the last twelve months. Net profit fell to $8.0M.

Operating margin went from 19.6% in 2016 to 11.1% in 2025, a fall of 8.5 percentage points. The most recent net margin is 6.35%. On a trailing twelve-month basis to Mar '26, revenue is $105.0M and net profit $7.0M.

Borrowings rose from $5.0M to $39.0M, cash from operations was $11.0M in the latest year, positive in 10 of the last 10.

Return on equity has averaged 6.4% over five years, and was 4.6% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

FONAR Corporation (FONR) — frequently asked questions